Metabolic Syndrome
Products for Metabolic Syndrome
- Cat.No. Product Name Information
- GC49671 2,3-Oxidosqualene An intermediate in the biosynthesis of sterols
- GC49176 5β-Tetrahydrocortisol An endogenous metabolite of cortisol
- GC18870 6-NBDG 6-NBDG is a non-hydrolyzable fluorescent glucose analog that is used to monitor glucose uptake and transport in living cells.
- GC45469 Hexacosanoic Acid-d4
- GC49373 L-Alanine-d3 An internal standard for the quantification of L-alanine
- GC44062 L-hydroxy Arginine (acetate) L-hydroxy Arginine is a substrate for nitric oxide synthase in the catabolism of L-arginine to form nitric oxide.
- GC49024 Palmitic Acid MaxSpec® Standard A quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications
- GC45779 Palmitic Acid-13C (C1 labeled) Palmitic Acid-13C (C1 labeled) is the 13C-labeled Palmitic acid.
- GC47859 Palmitic Acid-13C (C1, C2, C3, and C4 labeled) Palmitic Acid-13C (C1, C2, C3, and C4 labeled) is the 13C-labeled Palmitic acid.
- GC45976 Palmitic Acid-13C (C2 labeled) Palmitic Acid-13C (C2 labeled) is the 13C-labeled Palmitic acid.
- GC47860 Palmitic Acid-d2 An internal standard for the quantification of palmitic acid
- GC47861 Palmitic Acid-d31 An internal standard for the quantification of palmitic acid
- GC47862 Palmitic Acid-d5 An internal standard for the quantification of palmitic acid
- GC49023 Palmitic Acid-d9 MaxSpec® Standard A quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications
- GC44943 sPLA2 Inhibitor sPLA2 Inhibitor, a D-tyrosine derivative, is an orally active, potent secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 29 nM for human nonpancreatic secretory PLA2 isoform IIa (hnpsPLA2-IIa).
- GC45126 Uric Acid (sodium salt) Uric Acid (sodium salt) (Monosodium urate), scavenger of oxygen radical, is a very important antioxidant that help maintains the stability of blood pressure and antioxidant stress.